Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Specificity of Intradermal Test With Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers

NCT05203068 is registered in ClinicalTrials.gov with National Medical Research Center of Phthisiopulmonology and Infectious Diseases as lead sponsor.

NCT NCT05203068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05203068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Specificity of Intradermal Test With Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers
Lead sponsor
National Medical Research Center of Phthisiopulmonology and Infectious Diseases
Phase
Not applicable
Overall status
Completed
Start date
November 24, 2021
Completion date
January 26, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis